The first few minutes of Monday’s trading session on European markets are seeing moderate gains across most stock indices. Futures, however, are not reflecting this trend. The German DAX is down 0.27%, while the EU50 is down 0.3%. Investors continue to focus their attention on new reports regarding the conflict in the Middle East, which remain highly ambiguous. In the background, the Q1 earnings season is also becoming increasingly prominent, and it will be the main focus on Wednesday and Thursday.
Current prices of European contracts. Source: xStation
WHAT CAN WE EXPECT FROM TODAY'S SESSION AND THE REST OF THE WEEK?
• Trump is convening a Situation Room meeting with top national security advisors to assess the stalemate in negotiations with Iran and consider next steps. Any news coming out of this meeting could send shockwaves through the markets—particularly oil and futures contracts.
• Iran’s peace proposal is the main catalyst of the day – Trump has made it clear that he does not intend to lift sanctions until nuclear concessions are secured. The White House stated that it “will not negotiate through the press” and will accept only an agreement that permanently prevents Iran from obtaining nuclear weapons. The impasse continues.
• A key week for macroeconomic and corporate news: Fed (Wednesday), ECB and BoE (Thursday), BoJ, BoC. Data: US PCE, GDP, ISM Manufacturing PMI. Five companies from the “Mag 7” are reporting earnings—any disappointment at current valuations could trigger a sharp correction from historic highs.
The most important macroeconomic reports scheduled for this week are listed below ⬇️
Source: XTB
Company Earnings Calendar
Source: XTB
US Open: Week of Three Forces. Iran AI and Fed Put Markets to the Test!
⚫Brent Oil Hits Highest Since April 13
Chart of the day: OIL (27.04.2026)
Morning Wrap: Iran Presents Proposals on the Strait of Hormuz and the Nuclear Issue⚓ (27.04.2026)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
